https://www.taplowgroup.comInsight
https://www.taplowgroup.comTaplow
https://www.taplowgroup.comKnowledge
  • News
  • Cases
  • Downloads
Taplow News – 4th Pandemic Business Overview
18.05.2020

Taplow News – 4th Pandemic Business Overview

The Taplow Group has been active throughout the pandemic. This is the fourth in our ‘Biweekly Business Updates’ from our partners...
The 12 Steps for UK Hospitality to Bounce Back Beyond the Coronavirus Outbreak by Mark McMullen
14.05.2020

The 12 Steps for UK Hospitality to Bounce Back Beyond the Coronavirus Outbreak by Mark McMullen

UK hospitality businesses are likely to be currently focussing on how to deal with the effects of the coronavirus outbreak, but now is also the...
Taplow News – 3rd Pandemic Business Overview
04.05.2020

Taplow News – 3rd Pandemic Business Overview

The global pandemic has seen businesses affected across every sector, in all parts of the world.

First9101112131415161718Last

 CEO FOR A SPORTS:

Situation: A Finnish, mainly nationally operating sports company needed new CEO as the old one was about to retire. As sports business is one of the competence areas of our Finnish partner, we ended up delivering this search.

Read more …

For further Information please contac Timo Toivanen, Finland

 

 

 CEO FOR LOGISTICS:

Situation: One of the largest globally operating Logistics companies was in a need of new CIO for Finland. As Logistics and Value Chain is one of the competence areas of our Finnish partner, we ended up delivering this search.

Read more …

For further Information please contac Timo Toivanen, Finland

White Papers
  • India – The new R&D hub for Automotive

    Taplow India have conducted an in-depth review of the Automotive sector in India, For further information contact Sangeeta Sabharwal, India

    Click Here
  • Maysam Rizvi reviews the Banking Tech Revolution.

    Capital is more expensive, costs are higher and prices have gone down… the technology revolution has become a necessity.

    Click Here
  • EVOLVING BUSINESS UNITS Market Access thus becoming “transversal”

    The pharmaceutical market, in regards to the price component covered by the NHS, has been, until today, characterised by the presence of drugs of high therapeutic value, such as cancer-drugs, rheumatologic drugs, anti-infection drugs and drugs for the treatment of chronic illnesses, the vast majority of which have either seen their patent expire recently or will see it expire in the next two years.

    Click Here
  • BUSINESS CYCLES

    Present Human Capital Opportunities and Challenges:

    Click Here